written informed consent
Item
provide written informed consent to participate in the trial
boolean
C0021430 (UMLS CUI [1])
HIV-1 sero-positive
Item
hiv-1 sero-positive
boolean
C0019704 (UMLS CUI [1])
age
Item
male/female >18 years age
boolean
C0001779 (UMLS CUI [1])
receiving hiv protease inhibitor therapy
Item
currently receiving hiv protease inhibitor therapy for > 12 weeks and unlikely to require change in existing regimen during the 16 week study period
boolean
C0162714 (UMLS CUI [1])
fasting cholesterol
Item
fasting cholesterol > 6.5 mmol/l (mean of 2 samples collected > 3 days apart)
boolean
C1282513 (UMLS CUI [1])
ability to comply with study
Item
any condition which may interfere with ability to comply with study
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
gastrointestinal disorder
Item
gastrointestinal disorder which may affect drug absorption
boolean
C0017178 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
hypertension or congestive cardiac failure
Item
hypertension or congestive cardiac failure
boolean
C0020538 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
lactic acidemia
Item
lactic acidemia (serum lactate level >2.2 mmol/l)
boolean
C0347959 (UMLS CUI [1])
serious medical condition
Item
any serious medical condition which may compromise the patient’s safety, including pancreatitis or hepatitis within past 6 months
boolean
C0009488 (UMLS CUI [1,1])
C1113679 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
active aids
Item
active aids defining conditions
boolean
C0001175 (UMLS CUI [1])
lipid lowering agents oral hypoglycaemics anabolic steroids or insulin
Item
concurrent therapy with any other lipid lowering agents, oral hypoglycaemics, anabolic steroids or insulin
boolean
C0003367 (UMLS CUI [1])
C0359086 (UMLS CUI [2])
C0002845 (UMLS CUI [3])
C0021641 (UMLS CUI [4])